You are using an older browser version. Please use a supported version for the best MSN experience.

Vaccines and Related Biological Products Advisory Committee – 10/26/2021

Join the U.S. Food and Drug Administration for an upcoming meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss newly available data for the currently available COVID-19 vaccines. The committee will meet to discuss a request to amend Pfizer-BioNTech’s Emergency Use Authorization (EUA) for administration of their COVID-19 mRNA vaccine to children 5 through 11 years of age.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon